Madrigal Share Price
NASDAQ: MDGL | Mid Cap | HealthcareMadrigal Stock Performance
Madrigal Share Price Today
As of 20 November 2026, Madrigal Pharmaceuticals, Inc.'s share price is $396.59. The stock opened at $401.19, compared to its previous close of $397.16. During today's trading session, Madrigal Pharmaceuticals, Inc.'s share price traded between $393.93 and $409.52, with an average price of $401.73. Over the past 52 weeks, the stock has recorded a high of $614.13 and a low of $354.15. In terms of performance, Madrigal Pharmaceuticals, Inc.'s share price has declined by 20.19% over the last six months and is down 33.58% on a year-on-year basis.
Madrigal Share Price Chart
Madrigal Quarterly Profit & Loss
All figures in USD
Madrigal Annual Profit & Loss
All figures in USD
Madrigal Balance Sheet
All figures in USD Million
Madrigal Cash Flow
All figures in USD Million
About Madrigal
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Madrigal Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $431.14 | $396.30 | -7.87% |
Oct 2026 | $503.21 | $430.13 | -14.62% |
Sep 2026 | $544.35 | $503.77 | -7.30% |
Aug 2026 | $468.70 | $543.45 | +16.19% |
Jul 2026 | $535.50 | $467.72 | -12.88% |
Jun 2026 | $494.44 | $536.85 | +8.03% |
May 2026 | $514.33 | $496.94 | -3.79% |
Apr 2026 | $544.66 | $516.53 | -1.27% |
Mar 2026 | $429.31 | $523.17 | +21.08% |
Feb 2026 | $486.09 | $432.09 | -11.58% |
Jan 2026 | $582.02 | $488.67 | -16.10% |
Dec 2025 | $591.94 | $582.42 | -2.46% |